Cosmo Fowler, M.D., from Emory University in Atlanta, and colleagues examined data from the TriNetX U.S. Collaborative Network to examine whether OSA modifies outcomes in patients with T2DM receiving ...
Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have ...
Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.
Talking With Docs on MSN
Could metformin extend your lifespan?
What happened after Michael J. Fox finally met Eric Stoltz 40 years after replacing the actor in 'Back to the Future' Bruce ...
A new large study suggests that a group of diabetes medications called GLP-1 receptor agonists may be better than metformin ...
US researchers have identified a gene on the X chromosome that drives inflammation in the female brain and explains the ...
Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...
Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...
A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...
6d
Why women's brains face higher risk: Scientists pinpoint X-chromosome gene behind MS and Alzheimer's
New research by UCLA Health has identified a sex-chromosome linked gene that drives inflammation in the female brain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback